Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?

Detaylı Bibliyografya
Asıl Yazarlar: Stewart, P, Tomlinson, J
Materyal Türü: Journal article
Dil:English
Baskı/Yayın Bilgisi: 2009
_version_ 1826292703821824000
author Stewart, P
Tomlinson, J
author_facet Stewart, P
Tomlinson, J
author_sort Stewart, P
collection OXFORD
description
first_indexed 2024-03-07T03:18:48Z
format Journal article
id oxford-uuid:b6ba8c37-1fd7-4120-b4c3-f4f64a8bddd6
institution University of Oxford
language English
last_indexed 2024-03-07T03:18:48Z
publishDate 2009
record_format dspace
spelling oxford-uuid:b6ba8c37-1fd7-4120-b4c3-f4f64a8bddd62022-03-27T04:43:02ZSelective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b6ba8c37-1fd7-4120-b4c3-f4f64a8bddd6EnglishSymplectic Elements at Oxford2009Stewart, PTomlinson, J
spellingShingle Stewart, P
Tomlinson, J
Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title_full Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title_fullStr Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title_full_unstemmed Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title_short Selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome: is the target liver, fat, or both?
title_sort selective inhibitors of 11beta hydroxysteroid dehydrogenase type 1 for patients with metabolic syndrome is the target liver fat or both
work_keys_str_mv AT stewartp selectiveinhibitorsof11betahydroxysteroiddehydrogenasetype1forpatientswithmetabolicsyndromeisthetargetliverfatorboth
AT tomlinsonj selectiveinhibitorsof11betahydroxysteroiddehydrogenasetype1forpatientswithmetabolicsyndromeisthetargetliverfatorboth